J Med Microbiol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fuse, E. T.
Right arrow Articles by Yamaguchi, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fuse, E. T.
Right arrow Articles by Yamaguchi, K.
Agricola
Right arrow Articles by Fuse, E. T.
Right arrow Articles by Yamaguchi, K.
J Med Microbiol 56 (2007), 305-312; DOI: 10.1099/jmm.0.46913-0
© 2007 Society for General Microbiology
ISSN 1473-5644

Role of Toll-like receptor 2 in recognition of Legionella pneumophila in a murine pneumonia model

Etsu T. Fuse1,2, Kazuhiro Tateda1, Yoshiaki Kikuchi1, Tetsuya Matsumoto3, Fumio Gondaira4, Arata Azuma2, Shoji Kudoh2, Theodore J. Standiford5 and Keizo Yamaguchi1

1 Department of Microbiology and Infectious Diseases, Toho University School of Medicine, Tokyo 143-8540, Japan

2 Fourth Department of Internal Medicine, Nippon Medical School, Tokyo, Japan

3 Department of Microbiology, Tokyo Medical University, Tokyo, Japan

4 Denkaseiken Co. Ltd, Gosenshi, Minami-motomachi 1-2-2, Niigata, Japan

5 Pulmonary and Critical Care Medicine, University of Michigan Medical School, Ann Arbor, MI 48109-0360, USA

Correspondence
Kazuhiro Tateda
kazu{at}med.toho-u.ac.jp

Received 25 August 2006
Accepted 27 October 2006


Legionella pneumophila is an intracellular organism and the major aetiological agent of Legionnaires' disease. Although recent progress has identified Toll-like receptors (TLRs) as receptors for recognition of pathogen-associated molecular patterns in a variety of micro-organisms, understanding the contribution of TLRs to the host response in L. pneumophila infection is still limited. This study examined the roles of TLR2 and TLR4 in murine L. pneumophila pneumonia and an in vitro infection model using bone-marrow-derived macrophages. TLR2-deficient mice, but not TLR4-deficient mice, demonstrated higher lethal sensitivity to pulmonary challenge with L. pneumophila than wild-type mice (P<0.05). Although no differences in pulmonary bacterial burden were observed among the mouse strains examined, lower values of macrophage inflammatory protein-2 (MIP-2), keratinocyte-derived cytokine and interleukin (IL)-6 and higher IL-12 levels were noted in lung homogenates of TLR2-deficient mice compared with the wild-type control and TLR4-deficient mice. Recruitment of inflammatory cells, particularly neutrophils, was severely disturbed in the lungs of TLR2-deficient mice. Reduced MIP-2 production was demonstrated in bone-marrow-derived macrophages from TLR2-deficient mice in response to live L. pneumophila and purified LPS of this strain, but not Escherichia coli LPS. These data highlight the involvement and importance of TLR2 in the pathogenesis of L. pneumophila pneumonia in mice. The results showed that TLR2-mediated recognition of Legionella LPS and subsequent chemokine-dependent cellular recruitment may be a crucial host innate response in L. pneumophila pneumonia.


Abbreviations: BAL, bronchoalveolar lavage; BALF, BAL fluid; BM-M{phi}s, bone-marrow-derived macrophages; EU, endotoxin units; IFN, interferon; IL, interleukin; KC, keratinocyte-derived cytokine; MIP-2, macrophage inflammatory protein-2; TLR, Toll-like receptor.


    INTRODUCTION
 TOP
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Legionella pneumophila is a Gram-negative intracellular pathogen that often causes a serious and life-threatening pneumonia in humans (Marston et al., 1994; Reingold, 1988). An epidemiological survey suggested that 17 000–50 000 patients are hospitalized with Legionella disease annually in the USA (Marston et al., 1994; Reingold, 1988) and high mortality rates reaching 10–50 % have been observed in these patients, especially in immunocompromised individuals (el-Ebiary et al., 1997; Pedro-Botet et al., 1998; Tkatch et al., 1998).

Legionella usually infects humans via inhalation of contaminated aerosols from waterborne environmental sources. In lung tissue, the bacteria multiply in several types of host cell, including macrophages, monocytes and alveolar epithelial cells (Horwitz & Silverstein, 1980; Mody et al., 1993; Nash et al., 1984). Previous studies have demonstrated the important role of Th1 cytokines, such as interferon (IFN)-{gamma}, interleukin (IL)-12 and IL-18, in L. pneumophila infection models (Brieland et al., 1998, 2000; Gebran et al., 1994; Salins et al., 2001; Skerrett & Martin, 1994) and in human samples from pneumonia patients (Tateda et al., 1998). Recently, we reported a crucial role of neutrophils as a source of IL-12 in driving Th1-type host responses in L. pneumophila pneumonia (Tateda et al., 2001a). Influx of inflammatory cells, macrophages and neutrophils to the site of infection is believed to be critical for host defence responses and immune processes (Carratala et al., 1994). Although robust production of chemokines, including macrophage inflammatory protein-2 (MIP-2), keratinocyte-derived cytokine (KC) and LPS-induced CXC chemokine, has been demonstrated in a murine model of Legionella pneumonia (Tateda et al., 2001b), the pathogenesis of the disease, particularly the mechanisms by which this organism is sensed by host cells and by which the innate immune response is triggered, remains to be elucidated.

The first line of defence against invading bacteria is provided by the innate immune system, which recognizes pathogen-associated molecular patterns, conserved microbial patterns shared by large groups of pathogens but not found in higher eukaryotes (Medzhitov, 2001; Medzhitov & Janeway, 2000; Zhang et al., 2000). Over the last few years, it has become evident that both the recognition and the subsequent response to pathogens are mainly transferred by members of the Toll-like receptor (TLR) family (Aderem & Ulevitch, 2000; Akira & Takeda, 2004; Beutler, 2004; Janeway & Medzhitov, 2002). At least 11 TLRs have been described so far, among which TLR2 and TLR4 are the best-investigated family members. TLR4 was originally recognized as a receptor for LPS of Gram-negative bacteria, whereas TLR2 has been designated the major receptor for Gram-positive bacteria by virtue of its capacity to recognize major cell-wall constituents, such as peptidoglycan, lipoteichoic acid and lipoproteins (Medzhitov, 2001; Takeda et al., 2003). However, recent progress in this field has demonstrated that LPS from certain bacteria, such as Bacteroides, Pseudomonas, Rhizobium and Legionella, is recognized mainly by TLR2, rather than by TLR4 (Erridge et al., 2004; Girard et al., 2003). Consistent with these results, Lettinga et al. (2002) demonstrated that, in pulmonary L. pneumophila infection, C3H/HeJ mice, which display a non-functional gene encoding TLR4, were indistinguishable from control C3H/HeN mice in multiple parameters such as bacterial growth, cytokine production and histopathological changes in the infected lungs. More recently, Akamine et al. (2005) demonstrated that intracellular growth of L. pneumophila was enhanced within bone-marrow-derived macrophages (BM-M{phi}s) from TLR2-deficient mice, but not from TLR4-deficient mice, although the lethal sensitivity of TLR2-deficient mice and an association between cellular responses to L. pneumophila LPS and pathogenesis of the disease remain to be clarified.

The present study was designed to investigate further the role(s) of TLR2 in the pathogenesis of L. pneumophila pneumonia. The data obtained from TLR-deficient mice clearly demonstrated that TLR2, but not TLR4, is a critical molecule for the elaboration of an antibacterial host response against L. pneumophila. The relative contribution and importance of TLRs for detecting live L. pneumophila and its LPS component were compared in BM-M{phi}s from TLR2- and TLR4-deficient and wild-type mice.


    METHODS
 TOP
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Mice. Specific-pathogen-free C57BL/6 mice (6–8 weeks old) were purchased from Charles River (Yokohama, Japan). TLR2- and TLR4-deficient mice (C57BL/6 JJcl) were purchased from Oriental Bio-Service (Tokyo, Japan). All animals were housed in a pathogen-free environment and received sterile food and water in the Toho University School of Medicine (Tokyo, Japan).

Bacteria. Clinical isolates of L. pneumophila Suzuki (Tateda et al., 2001a), a serogroup 1 strain originally isolated at Toho University Hospital, were grown for 3–4 days at 37 °C on buffered charcoal yeast extract (BCYE) agar supplemented with L-cysteine and ferric nitrates. A single colony was transferred to 3 ml buffered yeast extract broth and incubated overnight at 37 °C with constant shaking. The bacterial suspension was transferred to fresh buffered yeast extract broth as serial fivefold dilutions and incubated overnight under the same conditions as those described above. After confirmation of bacterial motility, the concentration of bacteria in the broth was determined by measuring the OD600. Post-exponential-phase bacteria were used as challenge organisms (Byrne & Swanson, 1998). The numbers of viable bacteria in the challenge suspensions were determined by plating and incubating organisms on BCYE agar for 4 days.

Escherichia coli LPS and preparation of L. pneumophila LPS. Commercially available E. coli LPS (O55 : B5; Difco) was used to stimulate BM-M{phi}s from TLR2- and TLR4-deficient and wild-type control mice. LPS of L. pneumophila Suzuki was prepared as described previously (Girard et al., 2003; Yoshizawa et al., 2005). For purification of LPS, the phenol re-extraction step was included to remove lipoprotein contaminants from the preparations. Purified LPS demonstrated an activity of 429 500 endotoxin units (EU) ml–1, which is equivalent to approximately 2x109–4x109 c.f.u. ml–1. As a weighable pellet of purified LPS was not obtained, LPS concentration was expressed in EU ml–1. Protein contamination in the purified LPS was determined to be <5 µg ml–1 in 429 500 EU ml–1 using a protein assay (Bio-Rad).

Induction of L. pneumophila pneumonia in mice. Animals were anaesthetized intramuscularly with 7 mg ketamine and 15 mg xylazine kg–1. The trachea was exposed and 30 µl bacterial suspension, or saline as a control, was injected directly into the trachea with a sterile 26-gauge needle. The skin incision was closed with surgical staple.

Lung harvesting for analysis. At designated time points, mice were sacrificed by CO2 asphyxia. Before lung removal, the pulmonary vasculature was perfused with 1 ml saline via the right ventricle. After removal, whole lungs were homogenized in 1 ml saline using a tissue homogenizer (Omni International) under a vented hood. Portions of homogenates (10 µl) were inoculated onto BCYE agar after serial 1 : 10 dilutions in saline. The remaining homogenates were incubated on ice for 30 min and then centrifuged at 1400 g for 10 min. The supernatants were collected, passed through a 0.45 µm filter (Kanto Chemical) and stored at –40 °C until use.

Bronchoalveolar lavage (BAL) and collection of BAL fluid (BALF). Mice were sacrificed on day 1 after inoculation with bacteria and BAL was performed. The trachea was exposed and intubated using a 1.7 mm outer diameter polyethylene catheter. BAL was performed by instilling 2 ml PBS containing 5 mM EDTA and BALF was pooled for each animal. Leukocyte numbers were counted with a haemocytometer. Cytospins were prepared, stained with May–Giemsa and differential cell counts were performed. The remaining BALF was stored at –40 °C until further analysis.

Preparation of BM-M{phi}s and stimulation with L. pneumophila and LPS. BM-M{phi}s were prepared from bone marrow exudates of mouse femurs, as described previously (Celada et al., 1984; Swanson & Isberg, 1995). The cells were seeded overnight in 96-well tissue culture plates (104 cells per well) and used for BM-M{phi} experiments. After the medium had been changed, BM-M{phi}s were infected with L. pneumophila at the indicated m.o.i. for 2 h. At the end of the infection period (time 0), non-phagocytosed and non-adherent bacteria were removed by two washes with medium. These cells were incubated at 37 °C in a humidified atmosphere containing 5 % CO2. At the indicated time points, culture supernatants were collected and the infected macrophages were lysed, as described previously (Yoshizawa et al., 2005). Harvested bacterial suspensions were plated on BCYE agar plates after serial tenfold dilutions and incubated at 37 °C for 4 days. In some experiments, BM-M{phi}s were incubated with LPS of L. pneumophila or E. coli at the indicated concentrations for 24 h. Supernatants of BM-M{phi} cultures were collected and centrifuged at 10 000 r.p.m. for 5 min. Samples were stored at –40 °C until used for ELISA.

ELISAs for MIP-2, KC, IL-6 and IL-12. The levels of each cytokine in the culture supernatant of cells and lung homogenates were determined using a commercially available ELISA kit (DuoSet, ELISA development system; R&D Systems), according to the manufacturer's instructions. The ELISA consistently detected MIP-2, KC, IL-6 and IL-12 concentrations of between 20 and 4000 pg ml–1. The ELISA did not cross-react with other chemokines or cyokines.

Statistical analysis. Statistical significance was determined using an unpaired, two-tailed, alternative Student's t-test. Survival curves were constructed using the Kaplan–Meier method and analysed using a log rank test. A value of P<0.05 was considered to be significant.


    RESULTS
 TOP
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Lethal sensitivity of TLR-deficient mice in L. pneumophila pneumonia

C57BL/6 control and TLR2- and TLR4-deficient mice were intratracheally challenged with L. pneumophila Suzuki strain (3x106 c.f.u. per mouse) and survival was assessed twice daily for 10 days after infection (Fig. 1Go). Wild-type mice started to die from day 4 after infection, with a survival rate of 70 % (14/20) at the end of the observation period. TLR4-deficient mice demonstrated similar kinetics in lethality to wild-type mice, with an overall survival rate of 60 % (12/20). In contrast, significantly higher mortality was observed in TLR2-deficient mice, as survival in these mice was only 35 % (7/20) (P<0.05). These data suggested a protective role for TLR2, but not TLR4, in this murine model of L. pneumophila pneumonia.


Figure 1
View larger version (13K):
[in this window]
[in a new window]

 
Fig. 1. Lethal sensitivity of TLR-deficient mice in L. pneumophila pneumonia. C57BL/6 control ({blacksquare}) and TLR2- ({blacktriangleup}) and TLR4- (bullet) deficient mice were challenged intratracheally with L. pneumophila Suzuki strain (3x106 c.f.u. per mouse) and mortality was observed twice daily for 10 days after infection. *, P<0.05 compared with the wild-type.

 
Bacterial burden in the lungs of mice with L. pneumophila pneumonia

After intratracheal inoculation of bacteria, mice were sacrificed on days 1, 2 and 3 and the number of bacteria in the lungs was determined as described in Methods (Fig. 2Go). Despite a significant difference in lethal sensitivity, there were no differences in bacterial number in the lungs of wild-type and TLR2- and TLR4-deficient mice (n=5). These data suggested that bacterial overgrowth in the lungs did not account for the higher lethal sensitivity observed in TLR2-deficient mice.


Figure 2
View larger version (28K):
[in this window]
[in a new window]

 
Fig. 2. Bacterial burden in the lungs of mice with L. pneumophila pneumonia. After intratracheal inoculation of bacteria, mice were sacrificed on days 1, 2 and 3 and the number of bacteria in the lungs was compared in wild-type (filled bars), TLR2-deficient (open bars) and TLR4-deficient (hatched bars) mice, as described in Methods (n=5).

 
MIP-2, KC, IL-6 and IL-12 in the lungs of mice with L. pneumophila

Next, we examined the production of MIP-2, KC, IL-6 and IL-12 in the lungs of wild-type and TLR2- and TLR4-deficient mice at the indicated time points (Fig. 3Go). IL-12 is required for the generation of protective Th1-type host responses against Legionella infection, whereas MIP-2 and KC are major chemokines involved in neutrophil recruitment. Although L. pneumophila infection induced an increase in the expression of the cytokines in all groups, the extent and pattern differed in the various mutant and wild-type strains. At early time points (6 and 12 h), a reduced production of MIP-2, KC and IL-6 was found in TLR2-deficient mice compared with that observed in wild-type and TLR4-deficient mice. Conversely, significantly higher levels of IL-12 were observed in TLR2-deficient mice than in the wild-type control at 18 and 24 h after infection. No significant differences in IL-12 levels were noted between wild-type and TLR4-deficient mice.


Figure 3
View larger version (36K):
[in this window]
[in a new window]

 
Fig. 3. Levels of MIP-2, KC, IL-6 and IL-12 in the lungs of mice with L. pneumophila pneumonia. Production of MIP-2 (a), KC (b), IL-6 (c) and IL-12 (d) was examined in the lungs of wild-type (filled bars), TLR2-deficient (open bars) and TLR4-deficient (hatched bars) mice. *, P<0.05 compared with wild-type.

 
In addition, we examined MIP-2 levels in BALF. Whilst no detectable levels of MIP-2 were observed in control uninfected mice, there was considerable expression of MIP-2 (approx. 400 pg ml–1) detected in BALF from the lungs of infected wild-type mice. In TLR4-deficient mice, a greater than twofold increase in MIP-2 in BALF was found compared with that detected in wild-type control mice. In contrast, the levels of MIP-2 were only approximately 50 % of that observed in infected wild-type animals, although this difference was not statistically significant. These data were consistent with the MIP-2 results in the lung homogenates and further suggested the importance of TLR2-mediated signalling, including MIP-2 production, in host responses against L. pneumophila infection.

Leukocyte accumulation in BALF

To understand further the higher mortality in TLR2-deficient mice in the absence of changes in bacterial clearance, leukocyte accumulation in the air space was examined in infected mice on day 1 (Table 1Go). Compared with uninfected animals, L. pneumophila administration resulted in an almost tenfold increase in BAL cells within the lungs of wild-type mice, of which >90 % were neutrophils. In TLR4-deficient mice, no substantial differences were observed in cell numbers and differentials from those of wild-type mice. Importantly, a drastic reduction in inflammatory cells was observed in TLR2-deficient mice. Total cell number and numbers of neutrophils, macrophages and lymphocytes in TLR2-deficient mice were reduced by 24.9, 23.4, 38.0 and 46.5 %, respectively, compared with wild-type mice with L. pneumophila infection. These data suggested a reduction in cellular infiltration, especially neutrophils, in the infected lungs of TLR2-deficient mice, but not TLR4-deficient mice, which was associated with a decrease in chemokine responses and with the higher mortality observed in TLR2-deficient mice.


View this table:
[in this window]
[in a new window]

 
Table 1. Cell numbers and differentiation in BALF of mice 1 day after infection

Wild-type and TLR2- and TLR4-deficient mice were intratracheally infected with L. pneumophila, as described in Methods. Mice were sacrificed on day 1 and BAL was performed (n=5). Total cell numbers of leukocytes were counted with a haemocytometer and differentiation of cells was examined in cytospin samples after staining with May–Giemsa.

 
BM-M{phi} responses to L. pneumophila and its LPS

To examine the cellular mechanisms accounting for higher mortality in TLR2-deficient mice, BM-M{phi}s from wild-type and TLR2- and TLR4-deficient mice (5x104 c.f.u. per well) were infected with L. pneumophila (day 0) and bacterial numbers and MIP-2 production were examined at the indicated time points (n=5). As shown in Fig. 4Go, the bacterial number of L. pneumophila decreased with time in culture. No differences were observed among wild-type and TLR2- and TLR-4-deficient mice when an m.o.i. of 10 was applied to the BM-M{phi}s. Next, we examined MIP-2 production in culture supernatants after stimulation with L. pneumophila, LPS isolated from L. pneumophila and E. coli LPS at various concentrations. L. pneumophila infection induced MIP-2 production from BM-M{phi}s of wild-type and TLR4-deficient mice in an m.o.i.-dependent manner, whereas significantly lower production levels of MIP-2 were noted in BM-M{phi}s of TLR2-deficient mice (Fig. 5aGo). To try to determine the molecules responsible for this effect, purified LPS from L. pneumophila Suzuki strain was used to stimulate macrophages. As shown in Fig. 5(b)Go, high levels of MIP-2 were produced by BM-M{phi}s isolated from wild-type and TLR4-deficient mice, whereas significantly less MIP-2 was produced from BM-M{phi}s isolated from TLR2-deficient mice in response to L. pneumophila LPS. As expected, TLR4-deficient macrophages did not respond to E. coli LPS, whereas TLR2-deficient macrophages produced amounts of MIP-2 that were comparable to that of wild-type macrophages when similarly stimulated. These data suggested that BM-M{phi}s from TLR2-deficient mice produced considerably less MIP-2 in response to L. pneumophila and its LPS compared with that produced in response to E. coli LPS. These data further support the importance of TLR2-mediated signalling in response to L. pneumophila LPS.


Figure 4
View larger version (13K):
[in this window]
[in a new window]

 
Fig. 4. Bacterial numbers in BM-M{phi}s infected with L. pneumophila. BM-M{phi}s of wild-type ({blacksquare}), TLR2-deficient ({blacktriangleup}) and TLR4-deficient (bullet) mice were infected with L. pneumophila at an m.o.i. of 10. At the indicated time points, viable bacterial numbers were examined as described in Methods (n=5).

 

Figure 5
View larger version (20K):
[in this window]
[in a new window]

 
Fig. 5. MIP-2 production by BM-M{phi}s in response to L. pneumophila and its LPS. (a) BM-M{phi}s of wild-type (WT) and TLR2- (T2) and TLR4- (T4) deficient mice were infected with L. pneumophila at an m.o.i. of 1 (hatched bars) or 10 (filled bars), or were left uninfected as a control (open bars). (b) BM-M{phi}s of wild-type (WT) and TLR2- (T2) and TLR4- (T4) deficient mice were incubated with L. pneumophila LPS at concentrations of 1000 (filled bars), 100 (hatched bars) or 10 (shaded bars) EU ml–1, or were incubated without LPS as a control (open bars). (c) BM-M{phi}s of wild-type (WT) and TLR2- (T2) and TLR4- (T4) deficient mice were incubated with E. coli LPS at concentrations of 1000 (filled bars), 100 (hatched bars) or 10 (shaded bars) ng ml–1 or were incubated without LPS as a control (open bars). Culture supernatants were collected 1 day after incubation and the concentrations of MIP-2 were determined (n=5).

 

    DISCUSSION
 TOP
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The present study is the first to demonstrate that TLR2- but not TLR4-deficient mice are more susceptible to pulmonary infection with L. pneumophila than wild-type mice. Our data demonstrated an impairment in chemokine production and recruitment of inflammatory cells in the lungs of TLR2-deficient mice infected with L. pneumophila. In addition, it was shown that macrophages lacking the TLR2 molecule produced less MIP-2 in response to L. pneumophila LPS, but not E. coli LPS. These data are consistent with previous reports that LPS of L. pneumophila is recognized by the host-cell receptor TLR2 but not TLR4 (Braedel-Ruoff et al., 2005; Girard et al., 2003), and further defined a crucial role for TLR2 in inflammatory cell responses and pathogenesis of L. pneumophila pneumonia.

Our data indicated that TLR2-deficient mice exhibited a higher mortality but no differences in lung bacterial burden. On the other hand, cytokine and chemokine responses in the lungs of TLR2-deficient mice were altered compared with those of TLR4-deficient and wild-type mice. These data suggest that the lethal sensitivity of TLR2-deficient mice to L. pneumophila pneumonia may be governed by host inflammatory responses, rather than by bacterial numbers in the lungs. In this regard, we have reported previously that neutrophil depletion by administration of granulocyte-specific monoclonal antibody RB6-8C5 sensitized mice to enhanced mortality as a result of L. pneumophila infection, which was associated with a shifting of the cytokine balance from Th1 (IFN-{gamma}, IL-12) towards Th2-type (IL-4, IL-10) host responses, but with no change in bacterial burden in the lungs (Tateda et al., 2001a). Although we did not observe a reduction in the Th1 cytokine IL-12 or skewing of the Th2-type host response (data not shown), lower levels of chemokines and severely reduced inflammatory cell accumulation were demonstrated in the lungs of TLR2-deficient mice. These findings may be associated with exaggerated mortality in TLR2-deficient mice with L. pneumophila pneumonia, as a blockade of CXC chemokine receptor-2, a receptor for CXC chemokines including MIP-2 and KC, strikingly enhances the mortality of infected animals (Tateda et al., 2001b). More recently, impairment of chemokine production and inflammatory cell recruitment, especially neutrophils, was reported in the lungs of TLR2-deficient mice in an aerosolized model of L. pneumophila pneumonia (Hawn et al., 2006).

Yoshida et al. (1991) reported that peritoneal macrophages from C3H/HeJ mice, which carry a non-functional gene encoding TLR4, are permissive for L. pneumophila growth, whereas macrophages from control C3H/HeN mice are resistant. In contrast, Lettinga et al. (2002) demonstrated that, in pulmonary L. pneumophila infection, C3H/HeJ mice were indistinguishable from control C3H/HeN mice in bacterial growth in infected lungs. Others have reported that intracellular growth of L. pneumophila was enhanced within TLR2-deficient macrophages compared with wild-type and TLR4-deficient mice (Akamine et al., 2005). In a mouse pneumonia model, genetic deletion of myeloid differentiation primary response gene-88 (MyD88), a major adaptor protein in TLR signalling, resulted in severe impairment of eradication of L. pneumophila from the lungs, whereas TLR2-deficient mice displayed only a modest reduction in the clearance of bacteria (Archer & Roy, 2006; Hawn et al., 2006). In our hands, no substantial differences in growth of L. pneumophila were observed between TLR2-deficient and wild-type mice in macrophages in vitro or in the in vivo pneumonia model. These data suggest that TLR2-mediated signalling and additional MyD88-dependent, TLR2-independent pathways may be essential for full protection against the growth of L. pneumophila in the lungs.

Several lines of evidence have demonstrated that TLRs are a critical sensor for pathogen-associated molecular patterns, such as LPS, peptidoglycan and flagella (Aderem & Ulevitch, 2000; Akira & Takeda, 2004; Beutler, 2004; Janeway & Medzhitov, 2002). Although TLR4 was originally recognized as a receptor for LPS of Gram-negative bacteria, a more comprehensive analysis demonstrated an expanded repertoire of TLRs that function in LPS recognition by host immune cells. The endotoxins of several pathogens, including Leptospira, Porphyromonas, Chlamydia and Rhizobium, have been reported to stimulate host cells through activation of TLR2 (Erridge et al., 2004; Girard et al., 2003; Hirschfeld et al., 2001; Werts et al., 2001). Girard et al. (2003) reported that LPS of L. pneumophila required TLR2 rather than TLR4 to elicit the expression of CD14 in bone marrow granulocytes. In addition, Braedel-Ruoff et al. (2005) reported that purified L. pneumophila LPS, as well as L. pneumophila (either viable or formalin killed), was able to activate bone marrow dendritic cells from TLR4-deficient mice, but failed to activate bone marrow dendritic cells from TLR2-deficient mice. Our data in BM-M{phi}s stimulated with L. pneumophila LPS are in line with these reports and further demonstrate TLR2 as a recognition molecule of L. pneumophila LPS for induction of MIP-2. The present results also demonstrate that higher concentrations of LPS are able to overcome the lack of TLR2, again suggesting the involvement of other factors. Recently, Hawn et al. (2003) reported that TLR5 plays an essential role in governing host cytokine responses and susceptibility to Legionella infection in humans through the sensing mechanism of flagellin of this organism. Moreover, several investigators, including us, have reported that Naip5- and caspase-1-dependent cytosolic recognition of flagellin and subsequent host responses may be a critical factor for restriction of L. pneumophila in macrophages and in the lungs (Molofsky et al., 2006; Ren et al., 2006; Zamboni et al., 2006). It is likely that cell-surface sensing by TLR(s) and cytosolic recognition by Naip5 may be collaborating and interacting for maximal induction of host innate immune responses, which is an exciting area for future Legionella research.

Probably associated with the above results, reduction of MIP-2, KC and IL-6 production was observed in the L. pneumophila-infected lungs of TLR2-deficient mice at early time points (6 and 12 h). These data were consistent with a recent report in which complete and partial impairment of chemokine/cytokine responses was demonstrated in the L. pneumophila-infected lungs of MyD88- and TLR2-deficient mice, respectively (Hawn et al., 2006). Conversely, we observed an increase in IL-12 at relatively later time points (18 and 24 h) after infection. Although the reason for this result is unknown, a plausible explanation is that exaggerated IL-12 production may be due to a feedback mechanism to compensate for the lack of adequate host responses. A better understanding of inter- and counter-regulation of related cytokines/chemokines in the setting of TLR deficiency is required.

Neumeister et al. (1998) demonstrated that L. pneumophila LPS was about 1000 times less potent in its ability to induce pro-inflammatory cytokines from Mono Mac 6 cells than LPS of members of the Enterobacteriaceae. Several investigators have suggested a unique structure of L. pneumophila LPS, such as lack of negatively charged groups, the presence of a hydrophobic outer core and the length of the fatty acid chains (Erridge et al., 2004; Girard et al., 2003; Hirschfeld et al., 2001; Knirel et al., 1996; Moll et al., 1997). From the viewpoint of evolutionary advantage, it will be of interest to consider the reasons for TLR2-mediated recognition and the relatively weak biological activity of L. pneumophila LPS. Future studies assessing the molecular mechanisms of receptor–ligand interaction between TLR2 and L. pneumophila LPS, and defining the disparity and functional significance of TLR2 or TLR4 signalling in the pathogenesis of a variety of infectious diseases, are warranted.


    ACKNOWLEDGEMENTS
 
We thank Soichiro Kimura and Yoshikazu Ishii for their helpful discussions. The authors also express their deep appreciation to Michele S. Swanson and Paul H. Edelstein for their critical suggestions. This work was supported by the Naito Foundation and grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan.


    REFERENCES
 TOP
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Aderem, A. & Ulevitch, R. J. (2000). Toll-like receptors in the induction of the innate immune response. Nature 406, 782–787.[CrossRef][Medline]

Akamine, M., Higa, F., Arakaki, N., Kawakami, K., Takeda, K., Akira, S. & Saito, A. (2005). Differential roles of Toll-like receptors 2 and 4 in in vitro responses of macrophages to Legionella pneumophila. Infect Immun 73, 352–361.[Abstract/Free Full Text]

Akira, S. & Takeda, K. (2004). Toll-like receptor signalling. Nat Rev Immunol 4, 499–511.[CrossRef][Medline]

Archer, K. A. & Roy, C. R. (2006). MyD88-dependent responses involving toll-like receptor 2 are important for protection and clearance of Legionella pneumophila in a mouse model of Legionnaires' disease. Infect Immun 74, 3325–3333.[Abstract/Free Full Text]

Beutler, B. (2004). Inferences, questions and possibilities in Toll-like receptor signalling. Nature 430, 257–263.[CrossRef][Medline]

Braedel-Ruoff, S., Faigle, M., Hilf, N., Neumeister, B. & Schild, H. (2005). Legionella pneumophila mediated activation of dendritic cells involves CD14 and TLR2. J Endotoxin Res 11, 89–96.[CrossRef]

Brieland, J. K., Remick, D. G., LeGendre, M. L., Engleberg, N. C. & Fantone, J. C. (1998). In vivo regulation of replicative Legionella pneumophila lung infection by endogenous interleukin-12. Infect Immun 66, 65–69.[Abstract/Free Full Text]

Brieland, J. K., Jackson, C., Hurst, S., Loebenberg, D., Muchamuel, T., Debets, R., Kastelein, R., Churakova, T., Abrams, J. & other authors (2000). Immunomodulatory role of endogenous interleukin-18 in gamma interferon-mediated resolution of replicative Legionella pneumophila lung infection. Infect Immun 68, 6567–6573.[Abstract/Free Full Text]

Byrne, B. & Swanson, M. S. (1998). Expression of Legionella pneumophila virulence traits in response to growth conditions. Infect Immun 66, 3029–3034.[Abstract/Free Full Text]

Carratala, J., Gudiol, F., Pallares, R., Dorca, J., Verdaguer, R., Ariza, J. & Manresa, F. (1994). Risk factors for nosocomial Legionella pneumophila pneumonia. Am J Respir Crit Care Med 149, 625–629.[Abstract]

Celada, A., Gray, P. W., Rinderknecht, E. & Schreiber, R. D. (1984). Evidence for a gamma-interferon receptor that regulates macrophage tumoricidal activity. J Exp Med 160, 55–74.[Abstract/Free Full Text]

el-Ebiary, M., Sarmiento, X., Torres, A., Nogue, S., Mesalles, E., Bodi, M. & Almirall, J. (1997). Prognostic factors of severe Legionella pneumonia requiring admission to ICU. Am J Respir Crit Care Med 156, 1467–1472.[Abstract/Free Full Text]

Erridge, C., Pridmore, A., Eley, A., Stewart, J. & Poxton, I. R. (2004). Lipopolysaccharides of Bacteroides fragilis, Chlamydia trachomatis and Pseudomonas aeruginosa signal via toll-like receptor 2. J Med Microbiol 53, 735–740.[Abstract/Free Full Text]

Gebran, S. J., Yamamoto, Y., Newton, C., Klein, T. W. & Friedman, H. (1994). Inhibition of Legionella pneumophila growth by gamma interferon in permissive A/J mouse macrophages: role of reactive oxygen species, nitric oxide, tryptophan, and iron(III). Infect Immun 62, 3197–3205.[Abstract/Free Full Text]

Girard, R., Pedron, T., Uematsu, S., Balloy, V., Chignard, M., Akira, S. & Chaby, R. (2003). Lipopolysaccharides from Legionella and Rhizobium stimulate mouse bone marrow granulocytes via Toll-like receptor 2. J Cell Sci 116, 293–302.[Abstract/Free Full Text]

Hawn, T. R., Verbon, A., Lettinga, K. D., Zhao, L. P., Li, S. S., Laws, R. J., Skerrett, S. J., Beutler, B., Schroeder, L. & other authors (2003). A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to Legionnaires' disease. J Exp Med 198, 1563–1572.[Abstract/Free Full Text]

Hawn, T. R., Smith, K. D., Aderem, A. & Skerrett, S. J. (2006). Myeloid differentiation primary response gene (88)- and toll-like receptor 2-deficient mice are susceptible to infection with aerosolized Legionella pneumophila. J Infect Dis 193, 1693–1702.[CrossRef][Medline]

Hirschfeld, M., Weis, J. J., Toshchakov, V., Salkowski, C. A., Cody, M. J., Ward, D. C., Qureshi, N., Michalek, S. M. & Vogel, S. N. (2001). Signaling by toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infect Immun 69, 1477–1482.[Abstract/Free Full Text]

Horwitz, M. A. & Silverstein, S. C. (1980). Legionnaires' disease bacterium (Legionella pneumophila) multiples intracellularly in human monocytes. J Clin Invest 66, 441–450.[Medline]

Janeway, C. A., Jr & Medzhitov, R. (2002). Innate immune recognition. Annu Rev Immunol 20, 197–216.[CrossRef][Medline]

Knirel, Y. A., Moll, H. & Zähringer, U. (1996). Structural study of a highly O-acetylated core of Legionella pneumophila serogroup 1 lipopolysaccharide. Carbohydr Res 293, 223–234.[CrossRef][Medline]

Lettinga, K. D., Florquin, S., Speelman, P., van Ketel, R., van der Poll, T. & Verbon, A. (2002). Toll-like receptor 4 is not involved in host defense against pulmonary Legionella pneumophila infection in a mouse model. J Infect Dis 186, 570–573.[CrossRef][Medline]

Marston, B. J., Lipman, H. B. & Breiman, R. F. (1994). Surveillance for Legionnaires' disease. Risk factors for morbidity and mortality. Arch Intern Med 154, 2417–2422.[Abstract]

Medzhitov, R. (2001). Toll-like receptors and innate immunity. Nat Rev Immunol 1, 135–145.[CrossRef][Medline]

Medzhitov, R. & Janeway, C., Jr (2000). Innate immunity. N Engl J Med 343, 338–344.[Free Full Text]

Mody, C. H., Paine, R., III, Shahrabadi, M. S., Simon, R. H., Pearlman, E., Eisenstein, B. I. & Toews, G. B. (1993). Legionella pneumophila replicates within rat alveolar epithelial cells. J Infect Dis 167, 1138–1145.[Medline]

Moll, H., Knirel, Y. A., Helbig, J. H. & Zähringer, U. (1997). Identification of an alpha-D-Manp-(1->8)-Kdo disaccharide in the inner core region and the structure of the complete core region of the Legionella pneumophila serogroup 1 lipopolysaccharide. Carbohydr Res 304, 91–95.[CrossRef][Medline]

Molofsky, A. B., Byrne, B. G., Whitfield, N. N., Madigan, C. A., Fuse, E. T., Tateda, K. & Swanson, M. S. (2006). Cytosolic recognition of flagellin by mouse macrophages restricts Legionella pneumophila infection. J Exp Med 203, 1093–1104.[Abstract/Free Full Text]

Nash, T. W., Libby, D. M. & Horwitz, M. A. (1984). Interaction between the legionnaires' disease bacterium (Legionella pneumophila) and human alveolar macrophages. Influence of antibody, lymphokines, and hydrocortisone. J Clin Invest 74, 771–782.[Medline]

Neumeister, B., Faigle, M., Sommer, M., Zähringer, U., Stelter, F., Menzel, R., Schütt, C. & Northoff, H. (1998). Low endotoxic potential of Legionella pneumophila lipopolysaccharide due to failure of interaction with the monocyte lipopolysaccharide receptor CD14. Infect Immun 66, 4151–4157.[Abstract/Free Full Text]

Pedro-Botet, M. L., Sabria-Leal, M., Sopena, N., Manterola, J. M., Morera, J., Blavia, R., Padilla, E., Matas, L. & Gimeno, J. M. (1998). Role of immunosuppression in the evolution of Legionnaires' disease. Clin Infect Dis 26, 14–19.[Medline]

Reingold, A. L. (1988). Role of legionellae in acute infections of the lower respiratory tract. Rev Infect Dis 10, 1018–1028.[Medline]

Ren, T., Zamboni, D. S., Roy, C. R., Dietrich, W. F. & Vance, R. E. (2006). Flagellin-deficient Legionella mutants evade caspase-1- and Naip5-mediated macrophage immunity. PLoS Pathog 2, e18.[CrossRef][Medline]

Salins, S., Newton, C., Widen, R., Klein, T. W. & Friedman, H. (2001). Differential induction of gamma interferon in Legionella pneumophila-infected macrophages from BALB/c and A/J mice. Infect Immun 69, 3605–3610.[Abstract/Free Full Text]

Skerrett, S. J. & Martin, T. R. (1994). Intratracheal interferon-gamma augments pulmonary defenses in experimental legionellosis. Am J Respir Crit Care Med 149, 50–58.[Abstract]

Swanson, M. S. & Isberg, R. R. (1995). Association of Legionella pneumophila with the macrophage endoplasmic reticulum. Infect Immun 63, 3609–3620.[Abstract]

Takeda, K., Kaisho, T. & Akira, S. (2003). Toll-like receptors. Annu Rev Immunol 21, 335–376.[CrossRef][Medline]

Tateda, K., Matsumoto, T., Ishii, Y., Furuya, N., Ohno, A., Miyazaki, S. & Yamaguchi, K. (1998). Serum cytokines in patients with Legionella pneumonia: relative predominance of Th1-type cytokines. Clin Diagn Lab Immunol 5, 401–403.

Tateda, K., Moore, T. A., Deng, J. C., Newstead, M. W., Zeng, X., Matsukawa, A., Swanson, M. S., Yamaguchi, K. & Standiford, T. J. (2001a). Early recruitment of neutrophils determines subsequent T1/T2 host responses in a murine model of Legionella pneumophila pneumonia. J Immunol 166, 3355–3361.[Abstract/Free Full Text]

Tateda, K., Moore, T. A., Newstead, M. W., Tsai, W. C., Zeng, X., Deng, J. C., Chen, G., Reddy, R., Yamaguchi, K. & Standiford, T. J. (2001b). Chemokine-dependent neutrophil recruitment in a murine model of Legionella pneumonia: potential role of neutrophils as immunoregulatory cells. Infect Immun 69, 2017–2024.[Abstract/Free Full Text]

Tkatch, L. S., Kusne, S., Irish, W. D., Krystofiak, S. & Wing, E. (1998). Epidemiology of Legionella pneumonia and factors associated with Legionella-related mortality at a tertiary care center. Clin Infect Dis 27, 1479–1486.[Medline]

Werts, C., Tapping, R. I., Mathison, J. C., Chuang, T.-H., Kravchenko, V., Saint Girons, I., Haake, D. A., Godowski, P. J., Hayashi, F. & other authors (2001). Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism. Nat Immunol 2, 346–352.[CrossRef][Medline]

Yoshida, S., Goto, Y., Miyamoto, H., Fujio, H. & Mizuguchi, Y. (1991). Association of Lps gene with natural resistance of mouse macrophages against Legionella pneumophila. FEMS Microbiol Immunol 4, 51–56.[CrossRef][Medline]

Yoshizawa, S., Tateda, K., Matsumoto, T., Gondaira, F., Miyazaki, S., Standiford, T. J. & Yamaguchi, K. (2005). Legionella pneumophila evades gamma interferon-mediated growth suppression through interleukin-10 induction in bone marrow-derived macrophages. Infect Immun 73, 2709–2717.[Abstract/Free Full Text]

Zamboni, D. S., Kobayashi, K. S., Kohlsdorf, T., Ogura, Y., Long, E. M., Vance, R. E., Kuida, K., Mariathasan, S., Dixit, V. M. & other authors (2006). The Birc1e cytosolic pattern-recognition receptor contributes to the detection and control of Legionella pneumophila infection. Nat Immunol 7, 318–325.[CrossRef][Medline]

Zhang, P., Summer, W. R., Bagby, G. J. & Nelson, S. (2000). Innate immunity and pulmonary host defense. Immunol Rev 173, 39–51.[CrossRef][Medline]




This article has been cited by other articles:


Home page
J. Immunol.Home page
G. Hajishengallis, M. Wang, G. J. Bagby, and S. Nelson
Importance of TLR2 in Early Innate Immune Response to Acute Pulmonary Infection with Porphyromonas gingivalis in Mice
J. Immunol., September 15, 2008; 181(6): 4141 - 4149.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
A. Bugarcic, K. Hitchens, A. G Beckhouse, C. A Wells, R. B Ashman, and H. Blanchard
Human and mouse macrophage-inducible C-type lectin (Mincle) bind Candida albicans
Glycobiology, September 1, 2008; 18(9): 679 - 685.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Schmeck, J. Lorenz, P. D. N'Guessan, B. Opitz, V. van Laak, J. Zahlten, H. Slevogt, M. Witzenrath, A. Flieger, N. Suttorp, et al.
Histone Acetylation and Flagellin Are Essential for Legionella pneumophila-Induced Cytokine Expression
J. Immunol., July 15, 2008; 181(2): 940 - 947.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
U. Bhan, G. Trujillo, K. Lyn-Kew, M. W. Newstead, X. Zeng, C. M. Hogaboam, A. M. Krieg, and T. J. Standiford
Toll-Like Receptor 9 Regulates the Lung Macrophage Phenotype and Host Immunity in Murine Pneumonia Caused by Legionella pneumophila
Infect. Immun., July 1, 2008; 76(7): 2895 - 2904.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fuse, E. T.
Right arrow Articles by Yamaguchi, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fuse, E. T.
Right arrow Articles by Yamaguchi, K.
Agricola
Right arrow Articles by Fuse, E. T.
Right arrow Articles by Yamaguchi, K.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL J MED MICROBIOL MICROBIOLOGY J GEN VIROL ALL SGM JOURNALS